Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simeon I Taylor

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Journal of the Endocrine Society|March 6, 2020
Letter to the Editor: "Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin"Simeon I Taylor
Diabetes/Metabolism Research and Reviews|January 23, 2015
Metabolic syndrome: an ill wind that blows some good?Simeon I Taylor
The Lancet. Diabetes & Endocrinology|December 10, 2017
GLP-1 receptor agonists: differentiation within the classSimeon I Taylor
Diabetes Care|September 22, 2020
The High Cost of Diabetes Drugs: Disparate Impact on the Most Vulnerable PatientsSimeon I Taylor
Diabetes Care|August 20, 2025
Comment on Griffin et al. Use of SGLT2i Versus DPP-4i as an Add-on Therapy and the Risk of PAD-Related Surgical Events (Amputation, Stent Placement, or Vascular Surgery): A Cohort Study in Veterans With Diabetes. Diabetes Care 2025;48:361-370Sayna Bagheri, Simeon I Taylor
The Journal of Clinical Investigation|July 3, 2019
Insulin: still a miracle after all these yearsFabrizio Barbetti, Simeon I Taylor
Trends in Endocrinology and Metabolism: TEM|May 19, 2026
Classical homeostatic physiology sheds light on vitamin D controversiesSimeon I Taylor, Zhinous S Yazdi
Diabetes|July 22, 2020
Smarter Modeling to Enable a Smarter InsulinSimeon I Taylor, Richard D DiMarchi
The Journal of Clinical Investigation|November 9, 2020
YIPF5 mutations cause neonatal diabetes and microcephaly: progress for precision medicine and mechanistic understandingToni I Pollin, Simeon I Taylor
The Journal of Clinical Investigation|February 13, 2018
Cardiovascular outcome trials of diabetes drugs: lessons learnedSimeon I Taylor, Bruce R Leslie
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Journal of the Endocrine Society|March 6, 2020
Letter to the Editor: "Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin"Simeon I Taylor
Diabetes/Metabolism Research and Reviews|January 23, 2015
Metabolic syndrome: an ill wind that blows some good?Simeon I Taylor
The Lancet. Diabetes & Endocrinology|December 10, 2017
GLP-1 receptor agonists: differentiation within the classSimeon I Taylor
Diabetes Care|September 22, 2020
The High Cost of Diabetes Drugs: Disparate Impact on the Most Vulnerable PatientsSimeon I Taylor
Diabetes Care|August 20, 2025
Comment on Griffin et al. Use of SGLT2i Versus DPP-4i as an Add-on Therapy and the Risk of PAD-Related Surgical Events (Amputation, Stent Placement, or Vascular Surgery): A Cohort Study in Veterans With Diabetes. Diabetes Care 2025;48:361-370Sayna Bagheri, Simeon I Taylor
The Journal of Clinical Investigation|July 3, 2019
Insulin: still a miracle after all these yearsFabrizio Barbetti, Simeon I Taylor
Trends in Endocrinology and Metabolism: TEM|May 19, 2026
Classical homeostatic physiology sheds light on vitamin D controversiesSimeon I Taylor, Zhinous S Yazdi
Diabetes|July 22, 2020
Smarter Modeling to Enable a Smarter InsulinSimeon I Taylor, Richard D DiMarchi
The Journal of Clinical Investigation|November 9, 2020
YIPF5 mutations cause neonatal diabetes and microcephaly: progress for precision medicine and mechanistic understandingToni I Pollin, Simeon I Taylor
The Journal of Clinical Investigation|February 13, 2018
Cardiovascular outcome trials of diabetes drugs: lessons learnedSimeon I Taylor, Bruce R Leslie
Pageof 6